LI-COR Biotechnology Press Releases

January 11, 2021 – LI-COR Biosciences Providing Direct Support to Customers in Italy

January 11, 2021 – Rakuten Medical, Inc. Acquires Key Assets and Manufacturing Technology from LI-COR Biosciences

July 7, 2020 – LI-COR Near-Infrared Assays and Technology Offer Insight to Coronavirus Researchers

January 27, 2020 – New JBC Manuscript Promotes Industry-Leading Best Practice Guidance on Antibody Validation via Western Blotting

December 10, 2019 – LI-COR Announces Partnership with The Antibody Registry

August 6, 2019 – LI-COR Biosciences Introduces DigiWest® to Accelerate Targeted Therapeutics Development

May 15, 2018 – LI-COR Announces New Biotech Distributor for Singapore, Malaysia, Thailand, and Vietnam

April 30, 2018 – LI-COR Announces New Biotech Distributor in Israel

April 13, 2018 – LI-COR Announces New Biotech Distributor in Korea

April 10, 2018 – LI-COR Announces New Biotech Distributor in Japan

July 6, 2017 – LI-COR Introduces Nucleic Acid Gel Analysis With A Safe, Consistent, Single-System Workflow

March 29, 2017 – LI-COR Sponsors Clinical Trial For Near Infrared Surgical Imaging

March 9, 2017 - Growing Concern Over Reliability of Experiments Adds Pressure for Researchers

June 20, 2016 – LI-COR Licenses IRDye technology to QVQ for Pre-Clinical Cancer Research

April 30, 2015 - Aspyrian Therapeutics Inc. Announces FDA Acceptance of an Investigational New Drug Application for RM-1929, a First-in-Class, Precision-Targeted Therapy for Cance

Mar 5, 2015 - Aura Biosciences Closes $21M Series B Financing - Prepares to enter clinical trials for the treatment of rare ocular cancers

Apr 21, 2010 - Study Published on Toxicity of IRDye®® 800CW Carboxylate in Sprague Dawley Rats

Dec 9, 2009 - Spectros and LI-COR Biosciences Enter an Agreement to Develop Real-Time Imaging Agents for Prostate and Ovarian Cancer Surgery.

Oct 21, 2009 - LI-COR Reports on Toxicity Study of its IRDye® 800CW Carboxylate at Global Imaging Summit in Berlin

Sep 10, 2007 - LI-COR Infrared Dye Successfully Completes Toxicity Studies

chat icon disabledLooking to chat with support? First, you will need to accept cookies.
Open Cookie Preferences
chat iconChat With Us
chat icon disabled